Cencora, Inc. (LON:0HF3)
London flag London · Delayed Price · Currency is GBP · Price in USD
288.71
+1.82 (0.64%)
At close: Jun 6, 2025

Revenue by Product

Fiscal year is October - September.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2020
Period Ending
Mar '25 Sep '24 Sep '23 Sep '22 Sep '21 2012 - 2020
US Human Health
275.67B
Log In
Log In
Log In
Log In
Upgrade
US Human Health Growth
13.41%
Log In
Log In
Log In
Log In
Upgrade
US Animal Health
5.51B
Log In
Log In
Log In
Log In
Upgrade
US Animal Health Growth
5.29%
Log In
Log In
Log In
Log In
Upgrade
Other Healthcare Solutions
5.71B
Log In
Log In
Log In
Log In
Upgrade
Other Healthcare Solutions Growth
5.24%
Log In
Log In
Log In
Log In
Upgrade
International Alliance Healthcare
23.35B
Log In
Log In
Log In
Log In
Upgrade
International Alliance Healthcare Growth
2.39%
Log In
Log In
Log In
Log In
Upgrade

EBIT by Product

Fiscal year is October - September.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2020
Period Ending
Mar '25 Sep '24 Sep '23 Sep '22 Sep '21 2012 - 2020
Pharmaceutical Distribution Services Segment Operating Income
-
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Distribution Services Segment Operating Income Growth
-
Log In
Log In
Log In
Log In
Upgrade
Total Other Segment Operating Income
-
Log In
Log In
Log In
Log In
Upgrade
Total Other Segment Operating Income Growth
-
Log In
Log In
Log In
Log In
Upgrade
US Healthcare Solutions Operating Income
3.20B
Log In
Log In
Log In
Log In
Upgrade
US Healthcare Solutions Operating Income Growth
13.86%
Log In
Log In
Log In
Log In
Upgrade
International Healthcare Solutions Operating Income
674.46M
Log In
Log In
Log In
Log In
Upgrade
International Healthcare Solutions Operating Income Growth
-8.31%
Log In
Log In
Log In
Log In
Upgrade